FDA's Label Directive Pumps Up Plaintiffs In Drug Suits
The U.S. Food and Drug Administration might have unwittingly handed plaintiffs an attractive new weapon in failure-to-warn litigation against drugmakers when it revealed Tuesday that most prescription drugs do not adhere...To view the full article, register now.
Already a subscriber? Click here to view full article